Foresee Pharmaceuticals (Taiwan) Today
| 6576 Stock | TWD 83.90 0.90 1.08% |
PerformanceSolid
| Odds Of DistressBelow Average
|
Foresee Pharmaceuticals is selling for under 83.90 as of the 24th of March 2025; that is 1.08 percent increase since the beginning of the trading day. The stock's lowest day price was 82.0. Foresee Pharmaceuticals has about a 27 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat solid performance during the last 90 days. The performance scores are derived for the period starting the 24th of December 2024 and ending today, the 24th of March 2025. Click here to learn more.
Foresee Pharmaceuticals Co., Ltd., clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in Taiwan and Europe. Foresee Pharmaceuticals Co., Ltd. was founded in 2013 and is headquartered in Taipei, Taiwan. FORESEE PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.. The company has 118.12 M outstanding shares. More on Foresee Pharmaceuticals Co
Moving together with Foresee Stock
Moving against Foresee Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Foresee Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Foresee Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Foresee Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Benjamin Chien |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Foresee Pharmaceuticals Co (6576) is traded on Taiwan OTC Exchange in Taiwan and employs 29 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 12.58 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Foresee Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Foresee Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Foresee Pharmaceuticals operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 118.12 M outstanding shares.
Foresee Pharmaceuticals Co has accumulated about 1.34 B in cash with (213.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.47.
Check Foresee Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationForesee Pharmaceuticals holds a total of 118.12 Million outstanding shares. Foresee Pharmaceuticals Co retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Foresee Ownership Details
Foresee Pharmaceuticals Risk Profiles
Although Foresee Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Foresee Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.6323 | |||
| Semi Deviation | 0.4435 | |||
| Standard Deviation | 0.9686 | |||
| Variance | 0.9381 |
Foresee Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Foresee Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Foresee Pharmaceuticals Corporate Management
Elected by the shareholders, the Foresee Pharmaceuticals' board of directors comprises two types of representatives: Foresee Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Foresee. The board's role is to monitor Foresee Pharmaceuticals' management team and ensure that shareholders' interests are well served. Foresee Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Foresee Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sheila Chuang | Accounting Mang | Profile | |
| Mathieu Boudreau | Deputy General Manager-Business Development | Profile | |
| MengKung Chan | Chief Officer | Profile | |
| John Mao | Senior Deputy General Manager | Profile | |
| Liangshang Gan | General Manager | Profile | |
| David Lau | Senior Deputy General Manager-NCE Preclinical and Clinical Development | Profile | |
| Vincent Yen | Director | Profile |
Additional Tools for Foresee Stock Analysis
When running Foresee Pharmaceuticals' price analysis, check to measure Foresee Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foresee Pharmaceuticals is operating at the current time. Most of Foresee Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Foresee Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foresee Pharmaceuticals' price. Additionally, you may evaluate how the addition of Foresee Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.